drugset / Trial / NCT01450982
A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of JNJ-38518168 on the pharmacokinetics (how the body handles a drug) of methotrexate in participants with rheumatoid arthritis.
Timeline
- Start
- 2011-06
- Primary completion
- —
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | — | Oral |
| Subject | TOREFORANT | Small molecule | 100 mg | Oral |